Nucleic acid-polypeptide compositions and methods of inducing exon skipping
US-2026060996-A1 · Mar 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Geall Andrew John patents
Geall Andrew John is listed as an inventor on 54 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Geall Andrew John |
| Total patents | 54 |
| First publication | Nov 26, 2019 |
| Latest publication | Mar 5, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions and methods of treating muscle atrophy and myotonic dystrophy
US-2026007766-A1 · Jan 8, 2026 · US
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
US-2025381286-A1 · Dec 18, 2025 · US
Nucleic acid compositions and methods of multi-exon skipping
US-12497615-B2 · Dec 16, 2025 · US
Nucleic acid-polypeptide compositions and uses thereof
US-12364769-B2 · Jul 22, 2025 · US
Nucleic acid-polypeptide compositions and uses thereof
US-12351637-B2 · Jul 8, 2025 · US
Compositions and methods of treating muscle atrophy and myotonic dystrophy
US-2025195676-A1 · Jun 19, 2025 · US
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
US-2025170260-A1 · May 29, 2025 · US
Nucleic acid-polypeptide compositions and uses thereof
US-2025171544-A1 · May 29, 2025 · US
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
US-2025161344-A1 · May 22, 2025 · US
Recent patents
Latest publications not already listed above.
Nucleic acid-polypeptide compositions and uses thereof
US-2025152726-A1 · May 15, 2025 · US
Compositions and methods of treating muscle atrophy and myotonic dystrophy
US-12263224-B2 · Apr 1, 2025 · US
Nucleic acid-polypeptide compositions and uses thereof
US-12234290-B2 · Feb 25, 2025 · US
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
US-2024358736-A1 · Oct 31, 2024 · US
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
US-12064483-B2 · Aug 20, 2024 · US
Compositions and methods of treating muscle atrophy and myotonic dystrophy
US-11872287-B2 · Jan 16, 2024 · US
Compositions and methods of treating muscle atrophy and myotonic dystrophy
US-11712478-B2 · Aug 1, 2023 · US
Compositions and methods of treating muscle atrophy and myotonic dystrophy
US-2023201362-A1 · Jun 29, 2023 · US
Compositions and methods of treating muscle atrophy and myotonic dystrophy
US-2023201363-A1 · Jun 29, 2023 · US
Compositions and methods of treating muscle atrophy and myotonic dystrophy
US-11583591-B2 · Feb 21, 2023 · US
Compositions and methods of treating muscle atrophy and myotonic dystrophy
US-2023047754-A1 · Feb 16, 2023 · US
Compositions and methods of treating muscle atrophy and myotonic dystrophy
US-11576980-B2 · Feb 14, 2023 · US
Compositions and methods of treating muscle atrophy and myotonic dystrophy
US-11554176-B2 · Jan 17, 2023 · US
Nucleic acid-polypeptide compositions and uses thereof
US-2022395580-A1 · Dec 15, 2022 · US
Compositions and methods of treating muscle atrophy and myotonic dystrophy
US-11497814-B2 · Nov 15, 2022 · US
Nucleic acid-polypeptide compositions and uses thereof
US-2022324984-A1 · Oct 13, 2022 · US
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
US-2022313833-A1 · Oct 6, 2022 · US
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
US-11400163-B2 · Aug 2, 2022 · US
Nucleic acid compositions and methods of multi-exon skipping
US-2022235354-A1 · Jul 28, 2022 · US
Nucleic acid-polypeptide compositions and uses thereof
US-11364302-B1 · Jun 21, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Avidity Biosciences Inc | 54 |
| Avidity Biosciences Llc | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N15/113 | 54 |
| C12N2310/315 | 52 |
| C12N2310/3513 | 52 |
| A61K47/6807 | 51 |
| A61K31/713 | 48 |